Esperion Therapeutics, Inc. (LON:0IIM)
London
· Delayed Price · Currency is GBP · Price in USD 0.7862
-0.1139 (-12.65%)
At close: May 9, 2025
Esperion Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -153.22 | -51.75 | -209.25 | -233.66 | -269.11 | -143.55 | Upgrade
|
| Depreciation & Amortization | 0.09 | 0.06 | 0.16 | 0.5 | 0.61 | 0.55 | Upgrade
|
| Other Amortization | 1.76 | 1.5 | 1.7 | 1.62 | 1.62 | 1.74 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 12.5 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -0.41 | 0.28 | 0.01 | -0.1 | Upgrade
|
| Stock-Based Compensation | 11.22 | 11.99 | 11.96 | 15.22 | 24.31 | 28.39 | Upgrade
|
| Other Operating Activities | 66.74 | 75.07 | 46.68 | 44.59 | 31.26 | 19.56 | Upgrade
|
| Change in Accounts Receivable | -26.68 | -31.65 | -14.77 | -10.8 | -10.55 | -12.39 | Upgrade
|
| Change in Inventory | -26.23 | -28.87 | -30.42 | -0.81 | -18.26 | -16.14 | Upgrade
|
| Change in Accounts Payable | 43.73 | 12.43 | 8.68 | 5.6 | -34.1 | 23.11 | Upgrade
|
| Change in Unearned Revenue | -24.81 | -16.88 | 21.9 | -2.81 | 4.66 | -0.49 | Upgrade
|
| Change in Other Net Operating Assets | 7.29 | 4.44 | 28.29 | 5.44 | 5.74 | 1.65 | Upgrade
|
| Operating Cash Flow | -100.11 | -23.65 | -135.49 | -174.83 | -263.81 | -85.18 | Upgrade
|
| Capital Expenditures | -0.24 | -0.32 | - | - | - | -0.87 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | - | - | -12.5 | Upgrade
|
| Investment in Securities | - | - | 42.5 | 8.1 | -50.48 | 34.73 | Upgrade
|
| Investing Cash Flow | -0.24 | -0.32 | 42.5 | 8.1 | -50.48 | 21.36 | Upgrade
|
| Long-Term Debt Issued | - | 99.73 | - | - | - | 280 | Upgrade
|
| Long-Term Debt Repaid | - | -210.09 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -110.36 | -110.36 | - | - | - | 280 | Upgrade
|
| Issuance of Common Stock | 9.56 | 105.99 | 65.95 | 90.85 | 222.45 | 6.63 | Upgrade
|
| Repurchase of Common Stock | -343.75 | -343.75 | - | -50 | - | -55 | Upgrade
|
| Other Financing Activities | 432.94 | 434.6 | -15.49 | -8.24 | 45.77 | -29.91 | Upgrade
|
| Financing Cash Flow | -11.62 | 86.48 | 50.46 | 32.61 | 268.22 | 201.73 | Upgrade
|
| Net Cash Flow | -111.98 | 62.51 | -42.53 | -134.12 | -46.07 | 137.9 | Upgrade
|
| Free Cash Flow | -100.35 | -23.97 | -135.49 | -174.83 | -263.81 | -86.05 | Upgrade
|
| Free Cash Flow Margin | -38.66% | -7.21% | -116.46% | -231.64% | -336.29% | -37.81% | Upgrade
|
| Free Cash Flow Per Share | -0.52 | -0.13 | -1.31 | -2.63 | -9.13 | -3.13 | Upgrade
|
| Cash Interest Paid | - | 5.83 | 15.51 | 8.02 | - | - | Upgrade
|
| Levered Free Cash Flow | -80.85 | -43.62 | -107.24 | -135.56 | -192.19 | -77.82 | Upgrade
|
| Unlevered Free Cash Flow | -42.2 | -8.08 | -72.08 | -101.67 | -164.84 | -65.4 | Upgrade
|
| Change in Net Working Capital | 27.4 | 52.93 | -13.68 | 3.68 | 54.13 | 4.3 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.